Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Argus Health
US Department of Justice
Moodys
Queensland Health
Daiichi Sankyo
US Army
Citi
Mallinckrodt

Generated: April 25, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,149,054

« Back to Dashboard

Summary for Patent: 6,149,054
Title: Mechanical counter for a metering apparatus
Abstract:A metering apparatus for metering for example a medicament requires a device with which the number of metering portions is displayed. The known display devices however are not suitable for a metering apparatus having two housing portions which are rotatable relative to each other. The mechanical counter for a metering apparatus of that kind comprises at least one spindle with rotary locking, whose axis extends in parallel relationship with the axis of the metering apparatus and which is disposed in the region of a peripheral surface of the apparatus. The spindle is automatically driven by way of a transmission assembly when the metering apparatus is actuated. The number of metering portions already discharged and the number of petering portions permitted in total is quasi-continuously displayed by the mechanical counter. The transmission ration of the transmission assembly can be designed to cover a wide range. The cursor serving for display purposes can be reset on the spindle. The permissible period of use of a metering apparatus which can be used for a plurality of supply containers can be reliably viewed.
Inventor(s): Cirrillo; Pasquale (Dortmund, DE), Eicher; Joachim (Dortmund, DE), Fiol; Andreas (Wuppertal, DE)
Assignee: Boehringer Ingelheim International GmbH (Ingelheim, DE)
Application Number:09/091,999
Patent Claim Types:
see list of patent claims
Device; Use; Delivery;

Drugs Protected by US Patent 6,149,054

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 6,149,054

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany195 49 033Dec 28, 1995
PCT Information
PCT FiledDecember 19, 1996PCT Application Number:PCT/EP96/05758
PCT Publication Date:July 10, 1997PCT Publication Number: WO97/24586

International Family Members for US Patent 6,149,054

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Estonia 04165 ➤ Try a Free Trial
Egypt 21148 ➤ Try a Free Trial
European Patent Office 0870178 ➤ Try a Free Trial
European Patent Office 1254678 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Moodys
Dow
AstraZeneca
Citi
McKinsey
Teva
QuintilesIMS
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.